Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71276 - 71300 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	KCNN1	3780	downregulated	Silicon Dioxide analog results in decreased expression of KCNN1 mRNA	19p13.11	A24195
Silicon dioxide	Approved	KCNN2	3781	upregulated	Silicon Dioxide analog results in increased expression of KCNN2 mRNA	5q22.3	A24194
Silicon dioxide	Approved	KCNN3	3782	downregulated	Silicon Dioxide analog results in decreased expression of KCNN3 mRNA	1q21.3	A24195
Silicon dioxide	Approved	KCNN3	3782	upregulated	Silicon Dioxide analog results in increased expression of KCNN3 mRNA	1q21.3	A24194
Silicon dioxide	Approved	KCNQ1	3784	downregulated	Silicon Dioxide analog results in decreased expression of KCNQ1 mRNA	11p15.5-p15.4	A24195
Silicon dioxide	Approved	KCNQ1DN	55539	downregulated	Silicon Dioxide analog results in decreased expression of KCNQ1DN mRNA	11p15.4	A24195
Silicon dioxide	Approved	KCNS1	3787	downregulated	Silicon Dioxide results in decreased expression of KCNS1 mRNA	20q13.12	A24196
Silicon dioxide	Approved	KCNS3	3790	downregulated	Silicon Dioxide analog results in decreased expression of KCNS3 mRNA	2p24.2	A24195
Silicon dioxide	Approved	KCTD1	284252	downregulated	Silicon Dioxide analog results in decreased expression of KCTD1 mRNA	18q11.2	A24195
Silicon dioxide	Approved	KCTD13	253980	upregulated	Silicon Dioxide analog results in increased expression of KCTD13 mRNA	16p11.2	A24195
Silicon dioxide	Approved	KCTD15	79047	downregulated	Silicon Dioxide results in decreased expression of KCTD15 mRNA	19q13.11	A24196
Silicon dioxide	Approved	KCTD16	57528	downregulated	Silicon Dioxide analog results in decreased expression of KCTD16 mRNA	5q31.3	A24195
Silicon dioxide	Approved	KCTD8	386617	upregulated	Silicon Dioxide analog results in increased expression of KCTD8 mRNA	4p13	A24194
Silicon dioxide	Approved	KDM1B	221656	upregulated	Silicon Dioxide analog results in increased expression of KDM1B mRNA	6p22.3	A24195
Silicon dioxide	Approved	KDM2B	84678	upregulated	Silicon Dioxide analog results in increased expression of KDM2B mRNA	12q24.31	A24194
Silicon dioxide	Approved	KDM6B	23135	upregulated	Silicon Dioxide analog results in increased expression of KDM6B mRNA	17p13.1	A24195
Silicon dioxide	Approved	KDM7A	80853	downregulated	Silicon Dioxide analog results in decreased expression of KDM7A mRNA	7q34	A24195
Silicon dioxide	Approved	KDSR	2531	upregulated	Silicon Dioxide analog results in increased expression of KDSR mRNA	18q21.33	A24195
Silicon dioxide	Approved	KHDRBS1	10657	upregulated	Silicon Dioxide results in increased expression of KHDRBS1 mRNA	1p35.2	A24196
Silicon dioxide	Approved	KIAA0040	9674	upregulated	Silicon Dioxide results in increased expression of KIAA0040 mRNA	1q25.1	A24196
Silicon dioxide	Approved	KIAA0319L	79932	upregulated	Silicon Dioxide analog results in increased expression of KIAA0319L mRNA	1p34.3	A24195
Silicon dioxide	Approved	KIAA0408	9729	downregulated	Silicon Dioxide analog results in decreased expression of KIAA0408 mRNA	6q22.33	A24194
Silicon dioxide	Approved	KIAA0513	9764	downregulated	Silicon Dioxide analog results in decreased expression of KIAA0513 mRNA	16q24.1	A24195
Silicon dioxide	Approved	KIAA0754	643314	upregulated	Silicon Dioxide analog results in increased expression of KIAA0754 mRNA	1p34.2	A24195
Silicon dioxide	Approved	KIAA0895	23366	upregulated	Silicon Dioxide analog results in increased expression of KIAA0895 mRNA	7p14.2	A24194

Displaying entries 71276 - 71300 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability